Alaethes Wealth’s Adient ADNT Stock Holding History

Alaethes Wealth’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	–	–	106
2022 Q1	$0	Hold	9	–	–	﹤0.01%	294
2021 Q4	$0	Buy	+9	New	+$404	﹤0.01%	282
2021 Q3	–	Sell	-9	Closed	–	–	272
2021 Q2	$0	Buy	+9	New	+$421	﹤0.01%	259

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Greenvale Capital London, United Kingdom $916M AUM 32.73% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alaethes Wealth's ADNT Position: Q2 2022 in Review

Alaethes Wealth sold out of Adient (ADNT) in Q2 2022, closing a stake of 9 shares.

Alaethes Wealth first reported a position in ADNT in Q2 2021 and held it in 3 quarters. The position peaked at $0 in Q1 2022. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

Alaethes Wealth reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
Alaethes Wealth sold 9 Adient shares in Q2 2022.
Alaethes Wealth first reported a position in Adient in Q2 2021 and held it in 3 quarters.
Alaethes Wealth's Adient position peaked at $0 in Q1 2022.
258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on Alaethes Wealth's 13F filing for Q2 2022, filed 16 Aug 2022.